XNAS · LFCR
+3.94% · +$0.1800 · Vol 145.1K
Market closed · last close 4:00 PM ET · price as of 16:01:46 ET
Lifecore Biomedical, Inc. Common Stock

Lifecore Biomedical, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$4.75

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is LFCR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for LFCR are being assembled.
About Lifecore Biomedical, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
1996
Employees
382
Country
US

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.57
Day high
$4.80
Day low
$4.52
Previous close
$4.57
52W high
$5.83
-18.52% from high
52W low
$4.52
18% of range
Market cap
$171.4M
EPS
$-1.6800
Shares out
37.5M
Volume
145.1K
VWAP
$4.73
Price history computed in-house
1W
-8.57%
1M
-14.49%
SMA 50 $5.33 · below
SMA 200 $5.33 · below
52W position 18%
Veridion warehouse edge

Warehouse intelligence for LFCR.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

LFCR insider activity

Lifecore Biomedical, Inc. Common Stock

Score
Coverage building
Pressure
Net selling
Filings
3
Buys / sells
0 / 3
Net value
-$490K
Insiders
3
Named filers
JP
Josephs Paul
Insider
Leadership
SD
Salus Thomas D.
Insider
Leadership
LD
Lake Ryan David
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$490K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-05-212026-05-20Josephs PaulInsidersell$4.5740,413592,915$185KSEC Form 4
2026-04-162026-04-14Salus Thomas D.Insidersell$5.2024,645246,333$128KSEC Form 4
2025-09-042025-09-03Lake Ryan DavidInsidersell$7.7122,932336,691$177KSEC Form 4
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

LFCR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LFCR in this window.
Lobbying spend

LFCR lobbying filings, year to date.

Registered lobbying filings matched to Lifecore Biomedical, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LFCR in this window.
Latest news · LFCR
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for LFCR.
Options
Sovereign unlock shows live options positioning for LFCR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.